PANDAR, promoter of CDKN1A antisense DNA damage activated RNA, had significantly upregulated expression in tumor tissues and could serve as an independent predictor of overall survival in ccRCC [64]. Here, PANDAR is linked to nonpapillary renal cell carcinoma.